Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2025-12-26 @ 12:01 AM
Study NCT ID:
NCT06297668
Status:
COMPLETED
Last Update Posted:
2025-08-13
First Post:
2024-03-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess the Pharmacokinetics and Safety of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-Generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-11
Completion Date Type:
ACTUAL
First Submit Date:
2024-03-01
First Submit QC Date:
None
Study First Post Date:
2024-03-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-08
Last Update Post Date:
2025-08-13
Last Update Post Date Type:
ACTUAL